Differentiated Thyroid Cancer

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.

Lenvatinib in Locally Advanced Invasive Thyroid Cancer

Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial

Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy

Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.

Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma

Pembrolizumab in High-risk Thyroid Cancer

Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers

Empirical Radioactive Iodine Therapy in DTC

F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer

Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy

Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy

Iodine Uptake After a Low Iodine Diet

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy